Impact News +++ All You Need to Know About Stoke Therapeutics (STOK) Rating Upgrade to Buy (Zacks) +++ STOKE THERAPEUTICS Aktie -4,10%

Gewinn & Umsatz News zur BIO-TECHNE Aktie

>BIO-TECHNE Aktienkurs

51 EUR -4.7% (Tradegate)

Ask: 52.5 EUR / 190 Stück

Bid: 52 EUR / 200 Stück

Tagesumsatz: 140 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

BIO-TECHNE Aktie über LYNX handeln

Intraday

1 Jahr

>BIO-TECHNE Performance

1 Woche: -2,7%

1 Monat: 0%

3 Monate: +13,8%

6 Monate: +21,0%

1 Jahr: -21,9%

laufendes Jahr: -23,0%

>BIO-TECHNE Aktie

Name:

BIO-TECHNE CORP. DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US09073M1045 / A12ENG

Symbol/ Ticker:

TE1 (Frankfurt) / TECH (NASDAQ)

Kürzel:

FRA:TE1, ETR:TE1, TE1:GR, NASDAQ:TECH

Index:

S&P500

Webseite:

https://www.bio-techne.co..

Profil:

Bio-Techne Corporation is a leading developer and ..
>Volltext..

Marktkapitalisierung:

8300.65 Mio. EUR

Unternehmenswert:

8540.51 Mio. EUR

Umsatz:

1061.44 Mio. EUR

EBITDA:

327.67 Mio. EUR

Nettogewinn:

63.85 Mio. EUR

Gewinn je Aktie:

0.4 EUR

Schulden:

386.46 Mio. EUR

Liquide Mittel:

141.15 Mio. EUR

Operativer Cashflow:

250.26 Mio. EUR

Bargeldquote:

0.92

Umsatzwachstum:

-4.32%

Gewinnwachstum:

-60.31%

Dividende je Aktie:

0.27 EUR

Dividendenrendite:

0.52%

Dividendenschätzung:

0.52%

Div. Historie:

18.08.25 - 0.06863999€
19.05.25 - 0.06863999€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

BIO-TECHNE, BIO TECHNE

Letzte Datenerhebung:

05.11.25

>BIO-TECHNE Kennzahlen

Aktien/ Unternehmen:

Aktien: 155.69 Mio. St.

Frei handelbar: 98.84%

Leerverk. Aktien: 4.46%

Rückkaufquote: 2.35%

Mitarbeiter: 3100

Umsatz/Mitarb.: 0.34 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 10.08%

Bewertung:

KGV: 138.97

KGV lG: 30.73

KUV: 8.27

KBV: 5.09

PEG-Ratio: -

EV/EBITDA: 26.06

Rentabilität:

Bruttomarge: 66.44%

Gewinnmarge: 6.02%

Operative Marge: 21.86%

Managementeffizenz:

Gesamtkaprendite: 2.73%

Eigenkaprendite: 3.68%

>BIO-TECHNE Peer Group

Es sind 597 Aktien bekannt.

>BIO-TECHNE Chart & Kurs - NASDAQ

>BIO-TECHNE Gewinn & Umsatz News

05.11.25 - 13:42	Bio-Techne Corp. Q1 Profit Increases, Inline With Estimates (AFX)
	WASHINGTON (dpa-AFX) - Bio-Techne Corp. (TECH) reported a profit for its first quarter that Increases, from the same period last year in line with the Street estimates.The company's bottom line to......

14.10.25 - 14:54	Earnings Preview: What to Expect From Bio-Technes Report (Barchart)
	Bio-Techne will release its first-quarter earnings soon, and analysts anticipate the bottom line to remain unchanged year over year....

19.08.25 - 14:06	Bio-Techne Stock: Analyst Estimates & Ratings (Barchart)
	Bio-Techne has considerably underperformed the broader market over the past year, but analysts are moderately optimistic about the stock's prospects....

18.07.25 - 07:06	Bio-Techne′s Quarterly Earnings Preview: What You Need to Know (Barchart)
	Bio-Techne is expected to report its fiscal fourth-quarter earnings next month, and analysts forecast a modest single-digit decrease in its bottom line....

07.05.25 - 13:01	Bio-Techne Corp. Q3 Profit Decreases, But Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Bio-Techne Corp. (TECH) announced earnings for third quarter that decreased from the same period last year but beat the Street estimates.The company's bottom line totaled $2......

25.04.25 - 14:24	Bio-Technes Q3 2025 Earnings: What to Expect (Barchart)
	Bio-Techne is scheduled to release its fiscal third-quarter earnings next month, and analysts project a low single-digit bottom-line rise....

18.02.25 - 20:48	Bio-Techne Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
	Despite Bio-Techne's underperformance relative to the broader market over the past year, Wall Street analysts remain bullish on the stock's prospects....

05.02.25 - 13:01	Bio-Techne Corp. Q2 Profit Increases, Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Bio-Techne Corp. (TECH) announced earnings for its second quarter that increased from last year and beat the Street estimates.The company's bottom line totaled $34.89 millio......

20.01.25 - 10:06	Bio-Techne Earnings Preview: What to Expect (Barchart)
	Bio-Techne is expected to announce its second-quarter results in the upcoming month, and analysts expect earnings to remain stable, mirroring the year-ago quarter's results....

30.10.24 - 13:11	Bio-Techne rises after Q1 profit, revenue beat estimates (Reuters EN)
	Bio-Techne rises after Q1 profit, revenue beat estimates...

30.10.24 - 13:09	Bio-Techne beats quarterly profit estimates, driven by diagnostic unit growth; shares rise (Reuters EN)
	Bio-Techne beats quarterly profit estimates, driven by diagnostic unit growth; shares rise...

30.10.24 - 12:08	Bio-Techne Corp. Q1 Profit Decreases, But Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Bio-Techne Corp. (TECH) revealed earnings for first quarter that decreased from the same period last year but beat the Street estimates.The company's earnings totaled $33.60......

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Die Sprache des Baus braucht man manchmal auch im Management. - Mag. Dr. Martin Kriegner

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram